Top compounds associated with response to ZBTB25


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.006
mRNA tivozanib GDSC1000 pan-cancer AAC -0.096 0.006
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.097 0.007
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.1 0.007
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.007
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.082 0.007
mRNA skepinone-L CTRPv2 pan-cancer AAC 0.14 0.007
mRNA VX-11e GDSC1000 pan-cancer AAC -0.091 0.007
mRNA pac-1 CTRPv2 pan-cancer AAC 0.1 0.008
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.087 0.008
Download CSV